Clinical Trials Directory

Trials / Terminated

TerminatedNCT03765736

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

COLOMATE: Colorectal Cancer Liquid Biopsy Screening Protocol for Molecularly Assigned Therapy

Status
Terminated
Phase
Study type
Observational
Enrollment
199 (actual)
Sponsor
Academic and Community Cancer Research United · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial screens patients with colon or rectal cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable) for genetic mutations for recommendation to a molecularly assigned therapy. Identifying gene mutations may help patients enroll onto target companion trials that target these mutations.

Detailed description

PRIMARY OBJECTIVES: I. To perform blood-based genomic profiling on patients with treatment refractory metastatic colorectal cancer (CRC) to facilitate accrual to molecularly assigned therapies. II. To facilitate clinically annotated genomic analyses. OUTLINE: Patients submit blood samples for genetic testing.

Conditions

Interventions

TypeNameDescription
OTHERGenetic TestingUndergo genetic testing

Timeline

Start date
2020-04-20
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2018-12-05
Last updated
2025-08-29
Results posted
2024-01-23

Locations

18 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03765736. Inclusion in this directory is not an endorsement.